Solid organ transplantation is the gold standard replacement therapy in the event of organ failure. The most common being kidney, liver, pancreas, lung and heart transplantation. Despite improved and more potent immunosuppressive drug regimens, solid organ transplant patients still report physical and psychosocial symptoms that they have to live with and this at times impedes on good quality of life (QOL) including mental health. The immunosuppressive therapy regimens used are also associated with side effects that can affect quality of life. This module aims to discuss and manage the most common physical, psychosocial and drug related symptoms to support staff during management of patients who may experience such symptom.

After finalising this module, participants will be able to:

• identify patients at risk for malnutrition
• identify common symptom burden on patients in each organ transplant group
• discuss potential causes with patients to gain understanding
• discuss a management plan to relieve symptoms
• refer to appropriate health care professionals for further management if needed.

To obtain your credits, please complete the EACCME evaluation survey located under the tab "EACCME evaluation survey" in each module.